Why is Royalty Pharma Plc ?
- INTEREST(HY) At USD 187.34 MM has Grown at 39.88%
- INTEREST COVERAGE RATIO(Q) Lowest at 143.58
- CASH AND EQV(HY) Lowest at USD 1,445.28 MM
- Promoters have decreased their stake in the company by -0.56% over the previous quarter and currently hold 0.34% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Royalty Pharma Plc for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD 3,011.45 MM
Highest at 587.5%
Highest at USD 2.83
Highest at USD 674.14 MM
Fallen by -9,981% (YoY
At USD 187.34 MM has Grown at 39.88%
Lowest at 143.58
Lowest at USD 1,445.28 MM
Lowest at USD 134.41 MM
Lowest at 19.94 %
Lowest at USD 47.21 MM
Lowest at USD -16.39 MM
Lowest at USD 0.04
Here's what is working for Royalty Pharma Plc
Net Sales (USD MM)
DPS (USD)
Operating Cash Flows (USD MM)
DPR (%)
Raw Material Cost as a percentage of Sales
Depreciation (USD MM)
Here's what is not working for Royalty Pharma Plc
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Profit to Interest
Interest Paid (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Cash and Cash Equivalents






